Evidence map›Paper›PMID 34686260›Full record

ReviewCardiology clinics2021

Medical Management of Peripheral Artery Disease.

Tara A Holder, J Antonio Gutierrez, Aaron W Aday

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cardiology clinics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Tara A HolderDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, 383 PRB, Nashville, TN 37232-0021, USA. Electronic address: https://twitter.com/TaraHolder17.
J Antonio GutierrezDivision of Cardiology, Department of Medicine, Duke University Medical Center, DUMC 3330, Durham, NC 27710, USA. Electronic address: https://twitter.com/JAGutierrezMD.
Aaron W AdayDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, 383 PRB, Nashville, TN 37232-0021, USA; Vanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: aaron.w.aday@vumc.org.
Vanderbilt University Medical Center · USDuke Medical Center · US

Funding

The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery DiseaseK23HL151871 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ADAY, AARON W. · 2021 to 2025
$927k
NHLBI NIH HHS K23 HL151871
6 · The paper itself

Abstract

Peripheral artery disease is a highly morbid yet undertreated atherosclerotic disease. The cornerstones of peripheral artery disease therapy consist of smoking cessation, lipid-lowering therapy, and hypertension treatment. More recently, clinical trials have demonstrated that novel antiplatelet and antithrombotic therapies reduce the risk of both cardiovascular and limb events in this patient population. In this review, we highlight the components of optimal medical therapy of peripheral artery disease and the evidence base for these therapies.

Indexed as

AtherosclerosisPeripheral Arterial DiseaseHumansPlatelet Aggregation InhibitorsRisk FactorsPlatelet Aggregation InhibitorsAntiplatelet therapyAntithrombotic therapyPeripheral artery diseaseSmoking cessationStatins

Identifiers

PMID34686260
PMCPMC8544815
OpenAlexW3206964488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.